|
|
Volumn 1, Issue 2, 2009, Pages 93-103
|
|
4th European Antibody Congress 2008: December 1-3, 2008, Geneva, Switzerland
a,b
e
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ANTIBODY CONJUGATE;
ATLIZUMAB;
BIW 8405;
BLINATUMOMAB;
CD20 ANTIBODY;
CERTOLIZUMAB PEGOL;
CETUXIMAB;
CLOTINAB;
ECULIZUMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY;
GA 101;
IMMUNOGLOBULIN F(AB) FRAGMENT;
IMMUNOGLOBULIN FC FRAGMENT;
JUNCTIONAL ADHESION MOLECULE A;
KM 2760;
MDX 1203;
MDX 1401;
MONOCLONAL ANTIBODY;
NEUTRALIZING ANTIBODY;
OFATUMUMAB;
PANITUMUMAB;
RANIBIZUMAB;
REDITUX;
RILONACEPT;
RITUXIMAB;
SGN 35;
SOBLIDOTIN;
SYM 004;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VELTUZUMAB;
ANTIBODY COMBINING SITE;
ANTIBODY ENGINEERING;
ANTIBODY STRUCTURE;
ANTIGEN ANTIBODY COMPLEX;
B CELL LYMPHOMA;
BREAST CANCER;
CANCER CELL;
CENTRAL NERVOUS SYSTEM DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
ENZYME LINKED IMMUNOSORBENT ASSAY;
EPITOPE MAPPING;
GLYCOSYLATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
IMMUNOGENICITY;
LARGE CELL LYMPHOMA;
LIQUID CHROMATOGRAPHY;
MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;
METASTASIS;
MULTIPLE SCLEROSIS;
NONHODGKIN LYMPHOMA;
NONHUMAN;
PATENT;
RHEUMATOID ARTHRITIS;
STOICHIOMETRY;
STRUCTURE ACTIVITY RELATION;
TANDEM MASS SPECTROMETRY;
THROMBOCYTOPENIA;
XENOGRAFT;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BIOTECHNOLOGY;
DRUG DESIGN;
DRUG INDUSTRY;
HUMANS;
IMMUNOGLOBULIN G;
MICE;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
|
EID: 77953675199
PISSN: 19420862
EISSN: None
Source Type: Journal
DOI: 10.4161/mabs.1.2.7890 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
